News
-
-
-
-
PRESS RELEASE
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease. Expanded indication for broad protection. Key milestone in public health -
PRESS RELEASE
Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques
Sanofi obtient l'approbation de MenQuadfi pour les nourrissons de six semaines pour lutter contre les infections invasives à méningocoques en Union européenne -
PRESS RELEASE
Q3 2025/26: Environment remains challenging // »Precision« efficiency improvement programme implemented // Forecast for 2025/26 confirmed
All for One Group SE reports on Q3 2025/26 financial results, confirming forecast despite challenging environment. 'Precision' efficiency program implemented -
-
PRESS RELEASE
ADTRAN Holdings, Inc. reports second quarter 2026 financial results
ADTRAN Holdings, Inc. reports second quarter 2026 financial results with $281.1 million revenue, 6.1% year-over-year growth, and strategic priorities on track. Non-GAAP operating margin of 1.5% to 5.5% expected for Q3 2026 -
-